ArticleEClinicalMedicine2026
Validation of a deep learning model for bone fragility detection from conventional radiographs: an international cohort study.
Article in EClinicalMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Artificial Intelligence (AI)-based opportunistic risk stratification solutions can help to counter rising fragility fracture rates. Existing tools estimate bone mineral density (BMD) alone, while the present study incorporates trabecular bone score (TBS), a surrogate of bone microarchitecture, more closely mirroring fracture pathophysiology. We aimed to evaluate the performance of an AI tool that estimates bone fragility directly from standard radiographs to identify individuals at highest risk of fracture. Methods: This retrospective, multinational cohort study included 18,858 paired radiographs and lumbar spine dual-energy X-ray absorptiometry (DXA) scans from adult patients (aged at least 20 years) from three clinical sites in Europe and two sites in the United States. Routine clinical radiographs of the spine, abdomen, chest, or pelvis acquired in the anteroposterior or posteroanterior view and including visualisation of the lumbar spine were included. Eligible radiographs had an in-plane spatial resolution of ≤0.2 mm per pixel, independent of vendor, and had a corresponding DXA examination within 6 months, and included at least two lumbar vertebrae (L1-L4). The AI model training used a composite Bone Fragility Index, combining TBS and BMD. Training, internal validation and testing was performed on two European sites (n = 10,692; Italy and Austria); and external validation involved three sites with ethnically diverse populations (n = 7079): Slovakia, US site 1 (Wisconsin) and US site 2 (New York). Model performance for identifying very high bone fragility (characterised by degraded TBS and osteoporosis) prioritised specificity (as per the intended clinical use to prioritise low false-positive rates) and was evaluated with accuracy, sensitivity, specificity, AUC and precision. Findings: Between Jan 1, 2010 and Dec 31, 2023, 18,858 paired radiographs and lumbar spine dual-energy X-ray absorptiometry (DXA) scans from 11,138 participants across five international sites were retrospectively aggregated. Internal testing on two European sites demonstrated an accuracy of 0.86 (95% CI: 0.78, 0.92), specificity of 0.93 (0.85, 0.99), and sensitivity of 0.53 (0.41, 0.67). External testing on three sites demonstrated consistently high specificity of 0.88 (0.77, 0.99) in the European cohort, 0.94 (0.91, 0.97) in the American White dataset, and 0.96 (0.81, 0.99) in the American Non-White. External sensitivity ranged from 0.53 (0.41, 0.67) to 0.64 (0.50, 0.88). Interpretation: The proposed approach provides rapid identification of individuals with very high bone fragility from routine radiographs. Its specificity across diverse populations supports clinical use for opportunistic osteoporosis screening in real-world settings. Future work should assess the model's performance in more sex-balanced cohorts without prior DXA assessment, and evaluate its ability to predict incident fractures. Funding: The Swiss National Science Foundation, the Foundation of the Orthopaedic Hospital of the Vaudois University Hospital (Lausanne, Switzerland), and Medimaps Group SA, Switzerland.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.